Frontiers in Pharmacology | Pharmacology of Infectious Diseases

Original Research

Published on 13 Oct 2023

Head-to-head comparison of azvudine and nirmatrelvir/ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with propensity score matching

in Pharmacology of Infectious Diseases

An-Hua Wei
Lu Zeng
Lu Wang
Lin Gui
Wen-Ting Zhang
Xue-Peng Gong
Juan Li
Dong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274294

3,291 views
14 citations

Original Research

Published on 28 Sep 2023

Impact of selective reporting of antimicrobial susceptibility testing report on clinicians’ prescribing behavior of antibiotics

in Pharmacology of Infectious Diseases

Ying Wang
Xinping Zhang
Qian Zhou
Xiaojun Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1225531

2,611 views
1 citation

Review

Published on 27 Sep 2023

Exploring nanocomposites for controlling infectious microorganisms: charting the path forward in antimicrobial strategies

in Pharmacology of Infectious Diseases

Harish Saravanan
Tarunkarthick Subramani
Shobana Rajaramon
Helma David
Anusree Sajeevan
Swathi Sujith
Adline Princy Solomon

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1282073

4,680 views
18 citations

Brief Research Report

Published on 25 Sep 2023

Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China

in Pharmacology of Infectious Diseases

Li Sichen
Wang Rui
Yang Yue
Liu Xin
Cui Youbin
Tang Ze
Cai Hongfei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1263726

2,208 views
1 citation

Original Research

Published on 22 Sep 2023

Optimizing tylosin dosage for co-infection of Actinobacillus pleuropneumoniae and Pasteurella multocida in pigs using pharmacokinetic/pharmacodynamic modeling

in Pharmacology of Infectious Diseases

Eon-Bee Lee
Muhammad Aleem Abbas
Jonghyun Park
Dereje D. Tassew
Seung-Chun Park

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1258403

6,192 views
2 citations

Editorial

Published on 18 Sep 2023

Editorial: Re-emergence of neglected tropical diseases amid the COVID-19 pandemic: epidemiology, transmission, mitigation strategies, and recent advances in chemotherapy and vaccines

in Pharmacology of Infectious Diseases

Ranjan K. Mohapatra
Venkataramana Kandi
Veronique Seidel
Ali A. Rabaan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265803

2,126 views
7 citations

Review

Published on 06 Sep 2023

Recent insights about pyrrolidine core skeletons in pharmacology

in Pharmacology of Infectious Diseases

Samet Poyraz
H. Ali Döndaş
Naciye Yaktubay Döndaş
José M. Sansano

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1239658

44,212 views
35 citations

Review

Published on 05 Sep 2023

Treatment of non-tuberculosis mycobacteria skin infections

in Pharmacology of Infectious Diseases

Xin-Yu Wang
Qian-Nan Jia
Jun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242156

14,754 views
12 citations

Perspective

Published on 24 Aug 2023

Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials

in Pharmacology of Infectious Diseases

Ke-Wei Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228548

4,213 views
11 citations

Original Research

Published on 15 Aug 2023

Bryum billardieri Schwaegr. against EV71 infection: in vitro and in vivo antiviral effects, identification of molecular mechanisms and active monomers

in Pharmacology of Infectious Diseases

Yun-Yu Wang
Qian Li
Xiu-Wei Han
Xin-Huan Wan
Li Zhang
Feng-Jv Niu
Yi-Zhou Xin
Chang-Zheng Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1164784

2,152 views
1 citation

Original Research

Published on 08 Aug 2023

Evaluation of the effect of direct-acting antiviral agents on melatonin level and lipid peroxidation in chronic hepatitis C patients

in Pharmacology of Infectious Diseases

Nageh Ahmed El-Mahdy
Sabry Abou-Saif
Medhat Ismail Abd EL hamid
Heba M. Hashem
Mohamed Anwar Hammad
Sally El-Sayed Abu-Risha

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128016

1,873 views

Review

Published on 31 Jul 2023

The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19

in Pharmacology of Infectious Diseases

Binbin Xia
Li Zheng
Yali Li
Wenfang Sun
Yang Liu
Liushui Li
Jingyao Pang
Jing Chen
Jiaxin Li
Hua Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1098972

3,713 views
6 citations

Review

Published on 27 Jul 2023

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities

in Pharmacology of Infectious Diseases

Exequiel O. J. Porta
Karunakaran Kalesh
Patrick G. Steel

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1233253

7,856 views
26 citations

Review

Published on 26 Jul 2023

Individualized antibiotic dosage regimens for patients with augmented renal clearance

in Pharmacology of Infectious Diseases

A-Xi Shi
Qiang Qu
Hai-Hui Zhuang
Xin-Qi Teng
Wei-Xin Xu
Yi-Ping Liu
Yi-Wen Xiao
Jian Qu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1137975

10,273 views
20 citations

Perspective

Published on 19 Jul 2023

Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents

in Pharmacology of Infectious Diseases

Toshihiko Kakiuchi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1216433

3,000 views
2 citations

Brief Research Report

Published on 18 Jul 2023

Can BioSAXS detect ultrastructural changes of antifungal compounds in Candida albicans?–an exploratory study

in Pharmacology of Infectious Diseases

Kai Hilpert
Christoph Rumancev
Jurnorain Gani
Dominic W. P. Collis
Paula Matilde Lopez-Perez
Vasil M. Garamus
Ralf Mikut
Axel Rosenhahn

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1141785

1,966 views